The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
EGFR-TKI benefit for NSCLC patients with EML4-ALK rearrangement.
Zhijie Wang
No relevant relationships to disclose
Jie Wang
No relevant relationships to disclose
Yi Long Wu
No relevant relationships to disclose
Hua Bai
No relevant relationships to disclose
Xu-Chao Zhang
No relevant relationships to disclose
Tongtong An
No relevant relationships to disclose
Minglei Zhuo
No relevant relationships to disclose
Jianchun Duan
No relevant relationships to disclose
Lu Yang
No relevant relationships to disclose
Meina Wu
No relevant relationships to disclose